Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papulopustular Rosacea (PPR)”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT01494467
What this trial is testing

Phase 3 Papulopustular Rosacea Study

Who this might be right for
Papulopustular Rosacea
Galderma R&D 688
Testing effectiveness (Phase 2)Looking for participantsNCT07681271
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)

Who this might be right for
Papulopustular Rosacea
Novartis Pharmaceuticals 100
Testing effectiveness (Phase 2)Looking for participantsNCT06952517
What this trial is testing

Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

Who this might be right for
Papular-pustular RosaceaPapulopustular Rosacea (PPR)Papulopustular Rosacea
Narrows Institute for Biomedical Research 20
Large-scale testing (Phase 3)Study completedNCT01493947
What this trial is testing

CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

Who this might be right for
Papulopustular Rosacea
Galderma R&D 962
Large-scale testing (Phase 3)Study completedNCT01493687
What this trial is testing

Phase 3 Papulopustular Rosacea Study

Who this might be right for
Papulopustular Rosacea (PPR)
Galderma R&D 683